Samuel D. Riccitelli - Feb 28, 2022 Form 4 Insider Report for BIOCEPT INC (BIOC)

Role
Interim President and CEO, Director
Signature
/s/ Samuel D. Riccitelli
Stock symbol
BIOC
Transactions as of
Feb 28, 2022
Transactions value $
$0
Form type
4
Date filed
3/2/2022, 07:19 PM
Previous filing
Jul 20, 2021
Next filing
Jun 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOC Stock Option (right to buy) Award $0 +250K $0.00 250K Feb 28, 2022 Common Stock 250K $2.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall vest and become exercisable in 48 equal monthly installments from the vesting commencement date of February 28, 2022.